

For individuals at increased risk of breast cancer, early detection is not optional—it is essential. At Dr Seni’s specialist breast clinics in Birmingham, Solihull and Wolverhampton, high-risk patients benefit from personalised surveillance pathways, incorporating advanced imaging and risk-reduction strategies aligned with current UK guidance.
This guide explains who qualifies, what screening involves, and how proactive management can significantly reduce cancer-related risk.
Who Is High Risk?
You may be considered “high risk” for breast cancer if you meet one or more of the following criteria:
Genetic Risk
- Pathogenic variants in BRCA1 gene or BRCA2 gene
- Other hereditary syndromes (e.g. TP53, PALB2)
Family History
- Multiple first-degree relatives with breast or ovarian cancer
- Early-onset breast cancer in the family (under age 40–50)
Personal Risk Factors
- Previous breast cancer or atypical hyperplasia
- Prior chest radiotherapy (e.g. for lymphoma)
- High-risk scores on validated models (e.g. Tyrer-Cuzick)
NHS Risk Stratification
The NHS Breast Screening Programme categorises patients into:
- Average risk
- Moderate risk
- High risk
Featured snippet takeaway: High-risk patients are those with significant genetic mutations, strong family history, or prior high-risk pathology, requiring enhanced surveillance beyond routine screening.
Screening Options
High-risk screening is more intensive than routine population screening and typically includes:
Mammography
- Annual imaging from age 40 (or earlier depending on risk profile)
- Effective at detecting calcifications and structural abnormalities
Breast MRI
- Highly sensitive imaging, particularly useful in dense breast tissue
- Often recommended annually in high-risk patients
Ultrasound
- Adjunct tool for further lesion characterisation
Clinical Surveillance
- Regular specialist examination and symptom review
NHS guidance:
NICE recommends tailored screening protocols based on calculated lifetime risk.
External NHS resource:
Featured snippet takeaway: High-risk breast screening typically includes annual MRI and/or mammography, tailored to individual risk level.
MRI vs Mammogram
Understanding the difference is critical for informed decision-making:
Breast MRI
- Sensitivity: >90% for detecting invasive cancers
- Best for:
- Younger women
- Dense breast tissue
- Genetic mutation carriers
- Limitations:
- Higher false-positive rates
- Requires contrast injection
Mammography
- Gold standard for population screening
- Best for:
- Detecting microcalcifications
- Women over 40–50
- Limitations:
- Reduced sensitivity in dense breasts
Which Is Better?
Neither is universally “better”—they are complementary.
Featured snippet takeaway: MRI is more sensitive, especially in high-risk patients, while mammography remains essential for detecting calcifications—most high-risk pathways use both.
Prevention Strategies
High-risk screening is only one component—risk reduction is equally important.
Lifestyle Measures
- Maintain healthy weight
- Limit alcohol intake
- Regular physical activity
Medical Prevention
- Chemoprevention (e.g. tamoxifen in selected patients)
Surgical Options
- Risk-reducing mastectomy
- Risk-reducing salpingo-oophorectomy (for BRCA carriers)
Genetic Counselling
- Essential for individuals with strong family history
- Enables informed decisions about testing and prevention
NHS genetics services:
Featured snippet takeaway: Prevention strategies include lifestyle optimisation, medication, and in some cases preventive surgery, guided by genetic risk.
FAQs
Who qualifies for high-risk screening?
Patients with BRCA mutations, strong family history, prior chest radiotherapy, or high calculated lifetime risk qualify for enhanced screening pathways.
How often should I be screened?
- High-risk patients: typically annual MRI ± mammogram
- Moderate risk: often annual or 18-month mammography
Screening intervals are individualised.
Is MRI better than mammogram?
MRI is more sensitive, particularly in dense breasts, but mammography detects calcifications. Most high-risk patients require both modalities.
What if I carry BRCA?
Carriers of BRCA1 gene or BRCA2 gene:
- Require annual MRI from a younger age
- May consider preventive surgery
- Should undergo specialist genetic counselling
Can I book privately?
Yes. Private high-risk screening clinics offer:
- Rapid access (often within days)
- Same-day imaging
- Consultant-led assessment
This can complement or expedite NHS pathways.
Why Choose Dr Seni for High Risk Breast Screening in Birmingham, Solihull and Wolverhampton?
- Consultant breast surgeon with specialist expertise
- Personalised, risk-adapted screening plans
- Access to advanced MRI and imaging pathways
- Integrated care from risk assessment to prevention
Seni Mylvaganam
Consultant Oncoplastic Reconstructive and Cosmetic Breast Surgeon


